Free Trial Information
BioCentury | Jul 10, 2006
Strategy

Diagnostic precision

...In the commercial space, CPHD already has non-exclusive worldwide distribution rights to assays developed by Infectio Diagnostic Inc....
Read More
BioCentury | Oct 25, 2004
Company News

GeneOhm, Infectio Diagnostic deal

...with the assays. Financial details were not disclosed. GeneOhm Sciences Inc. , San Diego, Calif. Infectio Diagnostic Inc....
Read More
BioCentury | Mar 29, 2004
Clinical News

IDI-MRSA diagnostic to detect methicillin-resistant Staphylococcus aureus regulatory update

...take 2 to 5 days. The diagnostic is partnered with Cepheid Inc. (CPHD, Sunnyvale, Calif.). Infectio Diagnostic Inc....
Read More
BioCentury | Feb 23, 2004
Company News

Infectio Diagnostic, bioMérieux SA deal

...bioMerieux received a license from Infectio to IP related to bacterial resistance markers. Infectio Diagnostic Inc. , Quebec...
Read More
BioCentury | Jan 12, 2004
Company News

Chiron, Infectio Diagnostics Inc. deal

Infectio granted CHIR a license to nucleic acid-based technology to rapidly detect bacteria in platelets and blood products. Infectio also will transfer related R&D and manufacturing to CHIR. Chiron Corp. (CHIR), Emeryville, Calif. Infectio Diagnostics...
Read More
BioCentury | Nov 10, 2003
Company News

Cepheid, Infectio Diagnostics Inc. deal

The companies terminated their 2000 Aridia Corp. diagnostic joint venture and replaced it with multiple licensing deals (see BioCentury, May 22, 2000). CPHD received non-exclusive global distribution rights to Infectio's assays for Group B Streptococcus...
Read More
BioCentury | Nov 3, 2003
Clinical News

Screening test for methicillin-resistant Staphylococcus aureus regulatory update

...by year end and FDA approval by the end of the first quarter next year. Infectio Diagnostic Inc....
Read More
BioCentury | Nov 25, 2002
Clinical News

Group B Streptococcus regulatory update

...test IDI-Strep B runs on the Smart Cycler instrument from Cepheid Inc. (CPHD, Sunnyvale, Calif.). Infectio Diagnostic Inc....
Read More
BioCentury | Aug 26, 2002
Clinical News

Group B Streptococcus regulatory update

...develop tests that identify and detect bacterial and fungal infections (see BioCentury, May 22, 2000). Infectio Diagnostic Inc....
Read More
BioCentury | Aug 19, 2002
Company News

Infectio files 510(k)

Infectio Diagnostics (Sainte-Foy, Quebec) filed a 510(k) for FDA marketing clearance of a Group B Streptococcus (GBS) test for pregnant women in labor. The test IDI-Strep B is based on the Smart Cycler instrument from...
Read More
Items per page:
1 - 10 of 11
BioCentury | Jul 10, 2006
Strategy

Diagnostic precision

...In the commercial space, CPHD already has non-exclusive worldwide distribution rights to assays developed by Infectio Diagnostic Inc....
Read More
BioCentury | Oct 25, 2004
Company News

GeneOhm, Infectio Diagnostic deal

...with the assays. Financial details were not disclosed. GeneOhm Sciences Inc. , San Diego, Calif. Infectio Diagnostic Inc....
Read More
BioCentury | Mar 29, 2004
Clinical News

IDI-MRSA diagnostic to detect methicillin-resistant Staphylococcus aureus regulatory update

...take 2 to 5 days. The diagnostic is partnered with Cepheid Inc. (CPHD, Sunnyvale, Calif.). Infectio Diagnostic Inc....
Read More
BioCentury | Feb 23, 2004
Company News

Infectio Diagnostic, bioMérieux SA deal

...bioMerieux received a license from Infectio to IP related to bacterial resistance markers. Infectio Diagnostic Inc. , Quebec...
Read More
BioCentury | Jan 12, 2004
Company News

Chiron, Infectio Diagnostics Inc. deal

Infectio granted CHIR a license to nucleic acid-based technology to rapidly detect bacteria in platelets and blood products. Infectio also will transfer related R&D and manufacturing to CHIR. Chiron Corp. (CHIR), Emeryville, Calif. Infectio Diagnostics...
Read More
BioCentury | Nov 10, 2003
Company News

Cepheid, Infectio Diagnostics Inc. deal

The companies terminated their 2000 Aridia Corp. diagnostic joint venture and replaced it with multiple licensing deals (see BioCentury, May 22, 2000). CPHD received non-exclusive global distribution rights to Infectio's assays for Group B Streptococcus...
Read More
BioCentury | Nov 3, 2003
Clinical News

Screening test for methicillin-resistant Staphylococcus aureus regulatory update

...by year end and FDA approval by the end of the first quarter next year. Infectio Diagnostic Inc....
Read More
BioCentury | Nov 25, 2002
Clinical News

Group B Streptococcus regulatory update

...test IDI-Strep B runs on the Smart Cycler instrument from Cepheid Inc. (CPHD, Sunnyvale, Calif.). Infectio Diagnostic Inc....
Read More
BioCentury | Aug 26, 2002
Clinical News

Group B Streptococcus regulatory update

...develop tests that identify and detect bacterial and fungal infections (see BioCentury, May 22, 2000). Infectio Diagnostic Inc....
Read More
BioCentury | Aug 19, 2002
Company News

Infectio files 510(k)

Infectio Diagnostics (Sainte-Foy, Quebec) filed a 510(k) for FDA marketing clearance of a Group B Streptococcus (GBS) test for pregnant women in labor. The test IDI-Strep B is based on the Smart Cycler instrument from...
Read More
Items per page:
1 - 10 of 11